University of Notre Dame du Lac’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-577,616
Closed -$12.4M 2
2023
Q4
$12.4M Buy
+577,616
New +$12.4M 12.73% 2